FEMSOFT INSERT * 71202

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2001-03-30 for FEMSOFT INSERT * 71202 manufactured by Rochester Medical Corp..

Event Text Entries

[196882] Pt complained of s/s of a urinary tract infection. Given cipro 500 mg bid x 3 days. Uti resolved.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2130787-2001-00006
MDR Report Key323666
Report Source05
Date Received2001-03-30
Date of Report2001-03-28
Date of Event2001-03-11
Date Mfgr Received2001-03-26
Date Added to Maude2001-04-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactROB ANGLIN
Manufacturer StreetONE ROCHESTER MEDICAL DRIVE
Manufacturer CitySTEWARTVILLE MN 55976
Manufacturer CountryUS
Manufacturer Postal55976
Manufacturer Phone5075339613
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFEMSOFT INSERT
Generic NameFEMALE TRANSURETHRAL OCCLUSION DEVICE
Product CodeMNG
Date Received2001-03-30
Model Number*
Catalog Number71202
Lot NumberUNK
ID Number*
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key313149
ManufacturerROCHESTER MEDICAL CORP.
Manufacturer AddressONE ROCHESTER MEDICAL DR. STEWARTVILLE MN 55976 US
Baseline Brand NameFEMSOFT INSERT
Baseline Generic NameTRANSURETHRAL FEMALE URINARY OCCLUSION DEVICE
Baseline Catalog No71202
Baseline ID18 FR. 3.5 CM
Baseline Device FamilyFEMSOFT INSERT
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagY
Premarket ApprovalP9900
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2001-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.